Nam Ha Pharmaceutical ensures quality for consumers

Over more than six decades, Nam Ha Pharmaceutical has produced more than 200 modern and traditional medicinal products. Many brands have become popular among many generations of Vietnamese people, such as Bo Pho Nam Ha, Coldi-B Nasal Spray, Skinbibi Children's Cream, all recognized as 'Vietnam National Brands' in 2022.

Nam Ha's leaders insist the company conducts comprehensive research on its ingredients used in the production process for its flagship products and its new brands, such as Naphar Fresh and Cot Vi Vuong Nam Ha.

With a mission stating 'Green Medicine for a Healthy Life', Nam Ha has developed clean growing areas to help proactively source raw materials for production, ensuring competitiveness in the market. The Cat Canh growing area meets the World Health Organization's (WHO) Guidelines on Good Agricultural and Collection Practices for Medicinal Plants (GACP) in Bat Xat and Bac Ha districts, Lao Cai province.

Medicinal growing areas meet international standards

Most recently, the company formed a strategic cooperation with Bac Ha district in Lao Cai province, for the development of medicinal plant areas that meet GACP standards. Commenting on this partnership, the secretary of Bac Ha district said, "Medicinal herbs are one of the key crops in line with the district's development orientation. This partnership will contribute to the restructuring of crops and increase income for local people of Bac Ha."

The district is committed to creating better conditions for Nam Ha Pharmaceutical to invest in the development of medicinal herbs.

Beyond investing in growing areas, the preliminary processing and preparation of medicinal herbs are also standardised by Nam Ha. The company has invested in a system of warehouses across three regions in compliance with strict operation regulations. The company also adopts technology in line with the motto: Clean - Safety - Convenience.

Currently, Nam Ha Pharmaceutical has been proactive in sourcing clean medicinal herbs for a production system that meets the WHO's Good Manufacturing Practice (GMP) standards, overseen by the world's most advanced quality management system.However, there is a long way to go for Nam Ha to achieve its lofty goals. From 2022 to 2025, the company will develop national medicinal plant growing areas in some northern provinces and the Central Highlands for domestic production and export.

The company will actually finance the planning of medicinal plant growing areas in some provinces while offering support to cultivate and harvest medicinal plants in accordance with the natural conditions, soil, and farming practices of each region, in accordance with GACP standards. This will help ensure quality standards for local production and exports while creating stable jobs for farmers, members of cooperatives, and ethnic minority farmer groups, thereby contributing to economic development.

These are all strategic foundations to enhance the company's competitive advantage, control the quality of input materials, improve product quality, and achieve sustainable development goals in the future.

In its long-term vision, Nam Ha Pharmaceutical will invest in building a factory that meets FDA standards. Another key focus area of the company is training pharmacists to develop products to international standards. The company aims to produce high-quality pharmaceutical products for consumers, contributing to the development of Vietnam's pharmaceutical industry on the global market.

Proud of being a Vietnamese brand

Pharmaceuticals are a special field that affects human health and life. Therefore, the company ensures that the production process is monitored to comply with international standards. Recently, Nam Ha invested in six factories producing traditional medicines, modern medicines, and health foods with cutting-edge production lines meeting GMP and GLP standards.

Nam Ha Pharmaceutical also optimises consumer costs to match the income of the majority of Vietnamese people. The company offers reasonable selling prices and a distribution network of pharmacies across 63 localities.

Its products are very successful in the domestic market and Nam Ha is one of the few Vietnamese enterprises to market its pharmaceutical products overseas, bringing pride to Vietnam. The firm has exported its products to countries such as Russia, Cambodia, the Philippines, Bangladesh, Myanmar, and several African nations.

With these achievements, Nam Ha has become one of the major pharmaceutical companies in Vietnam. The company has received many prestigious titles and awards, including the National Quality Gold Award, and being recognised as one of the Top 5 prestigious Vietnamese traditional medicine companies and being among the Top 500 Large Enterprises. The company has also been honoured with the noble award of the Second-Class Labour Medal by the President.

Nam Ha Pharmaceutical has been voted Vietnamese High Quality Goods for 23 consecutive

In 2022, Nam Ha Pharmaceutical was named 'Vietnam National Brand'. The company recently scooped up the 2023 Vietnam High-Quality Goods Certificate.The certificate reflects that Nam Ha Pharmaceutical's products are always trusted and appreciated by consumers nationwide.

These awards serve as pride and motivation for the company to constantly improve product quality, to be worthy of the 'Vietnam National Brand' and the trust of consumers. Moving forward, the company aims to extend its reach to the international market in the near future.

Innovating Vietnam's pharmaceutical sector Traphaco JSC not only posted positive business results in 2021 but also registered an impressive momentum in the first quarter with an expected after-tax profit of $3.6 million, an increase of 50 per cent compared to the previous year. The pharmaceutical firm also makes shareholders and investors highly appreciate its progress in innovation and creativity, especially its corporate restructuring strategy.

Domestic pharmaceutical firms encouraged to produce rare medicines: official The Ministry of Health (MoH) will propose to the Government to issue policies aimed at encouraging domestic pharmaceutical enterprises to produce rare medicines in order to ensure domestic supply, said Deputy Minister of Health Nguyen Thi Lien Huong said at the Government’s regular press conference on October 29.

Retail businesses see potential in pharmaceutical retail In the context of rising inflation, many retail businesses can continue to grow thanks to bolstering their activities in the pharmaceutical sector.